NALFON Drug Patent Profile

✉ Email this page to a colleague

Which patents cover Nalfon, and when can generic versions of Nalfon launch?

Nalfon is a drug marketed by Key Therap and Dista and is included in two NDAs.

The generic ingredient in NALFON is fenoprofen calcium. There are nine drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the fenoprofen calcium profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Nalfon

A generic version of NALFON was approved as fenoprofen calcium by RISING on July 18^th, 2022.

Sign Up

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for NALFON?
What are the global sales for NALFON?
What is Average Wholesale Price for NALFON?

Summary for NALFON

US Patents:	0
Applicants:	2
NDAs:	2
Finished Product Suppliers / Packagers:	4
Raw Ingredient (Bulk) Api Vendors:	97
Patent Applications:	4,297
Drug Prices:	Drug price information for NALFON
What excipients (inactive ingredients) are in NALFON?	NALFON excipients list
DailyMed Link:	NALFON at DailyMed

Drug patent expirations by year for NALFON

Pharmacology for NALFON

Drug Class	Nonsteroidal Anti-inflammatory Drug
Mechanism of Action	Cyclooxygenase Inhibitors

US Patents and Regulatory Information for NALFON

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Key Therap	NALFON	fenoprofen calcium	CAPSULE;ORAL	017604-003	Approved Prior to Jan 1, 1982		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Dista	NALFON	fenoprofen calcium	TABLET;ORAL	017710-001	Approved Prior to Jan 1, 1982		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Key Therap	NALFON	fenoprofen calcium	CAPSULE;ORAL	017604-002	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Key Therap	NALFON	fenoprofen calcium	CAPSULE;ORAL	017604-004	Jul 21, 2009		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for NALFON

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Key Therap	NALFON	fenoprofen calcium	CAPSULE;ORAL	017604-003	Approved Prior to Jan 1, 1982	⤷ Sign Up	⤷ Sign Up
Dista	NALFON	fenoprofen calcium	TABLET;ORAL	017710-001	Approved Prior to Jan 1, 1982	⤷ Sign Up	⤷ Sign Up
Key Therap	NALFON	fenoprofen calcium	CAPSULE;ORAL	017604-002	Approved Prior to Jan 1, 1982	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for NALFON

See the table below for patents covering NALFON around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
Norway	132689		⤷ Sign Up
Malaysia	7400132	SUBSTITUTED PHENYLALKANOIC ACIDS AND DERIVATIVES THEREOF	⤷ Sign Up
Spain	370540		⤷ Sign Up
Israel	32825	SUBSTITUTED PHENYLALKANOIC ACIDS AND DERIVATIVES THEREOF	⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

AI Research Assistant

Questions you can ask:

Summary for NALFON

Pharmacology for NALFON

Make Better Decisions: Try a trial or see plans & pricing